The conference will open with a Welcome Cocktail Reception on the evening of Tuesday, May 6, and Aptar Pharma will sponsor a Gala Dinner at a scenic location in Estoril on Thursday, May 8.

Jones Financial Companies Lllp boosted its stake in AptarGroup, Inc. (NYSE:ATR – Free Report) by 310.4% in the fourth quarter, Holdings Channel reports. The fund owned 591 shares of the industrial ...

MISSOURI: A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their ...

Ultragenyx Pharmaceutical Inc. has a fifty-two week low of $37.02 and a fifty-two week high of $60.37. The business has a 50 day moving average price of $42.33 and a two-hundred day moving average ...

Merck built the new plant on the 262-acre campus it has occupied since 2004, where the pharma giant produces a variety of vaccines including shots to prevent chickenpox, measles and rubella.

NEW YORK, March 10, 2025 /PRNewswire/ -- Shareholder ... (Nasdaq: CKPT) to Sun Pharmaceutical Industries, Inc. The firm is concerned about conflicts relating to Checkpoint's controlling ...

Joshua Rhett Miller is a Newsweek chief investigative reporter based in New York. His areas of focus ... Representatives for Bayer — a Germany-based pharmaceutical and biotechnology giant ...

Sales in the domestic pharmaceutical market in February touched ₹18,781 crore, up 7.5% from a year earlier, data from B2B commerce platform Pharmarack showed. Overall, the moving annual total ...

Keep on introducing new products...In the next two years, the government is going to announce a new incentive policy for pharmaceutical research. That will be the beginning of an innovation ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 ...